Holven KB, Roeters van Lennep J(2023) Sex differences in lipids: A life course approach Atherosclerosis, 117270(in press) DOI 10.1016/j.atherosclerosis.2023.117270, PubMed 37730457
Strøm TB, Asprusten E, Laerdahl JK, Øygard I, Hussain MM, Bogsrud MP, Leren TP(2023) Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine J Clin Lipidol(in press) DOI 10.1016/j.jacl.2023.08.009, PubMed 37718180
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SFet al.(2023) Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia Cardiovasc Diabetol, 22(1), 233 DOI 10.1186/s12933-023-01963-9, PubMed 37653496